fluoromisonidazole has been researched along with allopurinol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grunbaum, Z; Krohn, KH; Prekeges, JL; Rasey, JS | 1 |
| Ball, C; Bejot, R; Carroll, L; Elizarov, AM; Gouverneur, V; Hill, S; Kelly, C; Kersemans, V; King, RC; Kolb, HC; Miraghaie, R; Smart, S; Zhang, J | 1 |
2 other study(ies) available for fluoromisonidazole and allopurinol
| Article | Year |
|---|---|
Reduction of fluoromisonidazole, a new imaging agent for hypoxia.
Topics: Animals; Cell Line; Fluorine Radioisotopes; Humans; Misonidazole; NADH Dehydrogenase; Nitroreductases; Oxidation-Reduction; Oxygen; Tomography, Emission-Computed; Xanthine Oxidase | 1991 |
Pre-clinical evaluation of a 3-nitro-1,2,4-triazole analogue of [18F]FMISO as hypoxia-selective tracer for PET.
Topics: Animals; Biomarkers; Cell Hypoxia; Cell Line, Tumor; Cell Transformation, Neoplastic; Chemical Phenomena; Drug Evaluation, Preclinical; Female; Glutathione; Kinetics; Mice; Misonidazole; Models, Biological; Neoplasms; Oxidation-Reduction; Positron-Emission Tomography; Propanols; Radioactive Tracers; Triazoles; Xanthine Oxidase | 2010 |